1. Home
  2. SGMT vs ISTR Comparison

SGMT vs ISTR Comparison

Compare SGMT & ISTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMT
  • ISTR
  • Stock Information
  • Founded
  • SGMT 2006
  • ISTR 2006
  • Country
  • SGMT United States
  • ISTR United States
  • Employees
  • SGMT N/A
  • ISTR N/A
  • Industry
  • SGMT
  • ISTR Major Banks
  • Sector
  • SGMT
  • ISTR Finance
  • Exchange
  • SGMT Nasdaq
  • ISTR Nasdaq
  • Market Cap
  • SGMT 230.3M
  • ISTR 219.7M
  • IPO Year
  • SGMT 2023
  • ISTR 2014
  • Fundamental
  • Price
  • SGMT $7.11
  • ISTR $23.14
  • Analyst Decision
  • SGMT Strong Buy
  • ISTR Buy
  • Analyst Count
  • SGMT 7
  • ISTR 1
  • Target Price
  • SGMT $26.57
  • ISTR $27.00
  • AVG Volume (30 Days)
  • SGMT 601.4K
  • ISTR 34.3K
  • Earning Date
  • SGMT 08-13-2025
  • ISTR 10-20-2025
  • Dividend Yield
  • SGMT N/A
  • ISTR 1.90%
  • EPS Growth
  • SGMT N/A
  • ISTR 46.46
  • EPS
  • SGMT N/A
  • ISTR 2.24
  • Revenue
  • SGMT N/A
  • ISTR $90,651,000.00
  • Revenue This Year
  • SGMT N/A
  • ISTR $10.96
  • Revenue Next Year
  • SGMT N/A
  • ISTR $61.82
  • P/E Ratio
  • SGMT N/A
  • ISTR $10.34
  • Revenue Growth
  • SGMT N/A
  • ISTR 12.41
  • 52 Week Low
  • SGMT $1.73
  • ISTR $15.39
  • 52 Week High
  • SGMT $11.41
  • ISTR $24.81
  • Technical
  • Relative Strength Index (RSI)
  • SGMT 39.46
  • ISTR 58.00
  • Support Level
  • SGMT $7.01
  • ISTR $22.77
  • Resistance Level
  • SGMT $7.68
  • ISTR $23.70
  • Average True Range (ATR)
  • SGMT 0.51
  • ISTR 0.47
  • MACD
  • SGMT -0.02
  • ISTR -0.00
  • Stochastic Oscillator
  • SGMT 39.03
  • ISTR 68.89

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

About ISTR Investar Holding Corporation

Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

Share on Social Networks: